Corrigendum.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 892, doi. 10.1002/mc.23444
- Publication type:
- Article
Works matching IS 08991987 AND DT 2022 AND VI 61 AND IP 9
Results: 8
1
2
Corrigendum.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 890, doi. 10.1002/mc.23443
- Publication type:
- Article
3
Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheres.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 876, doi. 10.1002/mc.23440
- By:
- Publication type:
- Article
4
Long noncoding RNA TFAP2A‐AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR‐1297 and regulating TFAP2A expression.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 865, doi. 10.1002/mc.23438
- By:
- Publication type:
- Article
5
Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 851, doi. 10.1002/mc.23437
- By:
- Publication type:
- Article
6
Targeting mitochondrial metabolism for metastatic cancer therapy.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 827, doi. 10.1002/mc.23436
- By:
- Publication type:
- Article
7
HIF‐1α‐regulated stanniocalcin‐1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 839, doi. 10.1002/mc.23420
- By:
- Publication type:
- Article
8
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 825, doi. 10.1002/mc.23319
- Publication type:
- Article